Dexmedetomidine intranasal for intrapartum fever prevention study

ClinicalTrials.gov added registration NCT07501221 for a Phase 2 interventional study titled 'Dexmedetomidine intranasal for intrapartum fever prevention study.' The trial evaluates the efficacy and safety of intranasal dexmedetomidine administered during labor for fever prevention, targeting pregnant patients in the intrapartum period.

Sponsors and clinical investigators conducting obstetric research should ensure this trial is captured in their clinical trial registries. Study staff should verify Good Clinical Practice compliance and IRB oversight. The trial registration demonstrates increased transparency requirements for perinatal drug studies using off-label or investigational intranasal formulations.